D.E. Shaw & Co’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-56,700
Closed -$914K 4811
2025
Q3
$914K Sell
56,700
-3,118
-5% -$50.5K ﹤0.01% 3511
2025
Q2
$957K Buy
59,818
+9,284
+18% +$140K ﹤0.01% 3259
2025
Q1
$864K Sell
50,534
-17,135
-25% -$358K ﹤0.01% 3179
2024
Q4
$1.68M Buy
67,669
+5,234
+8% +$148K ﹤0.01% 2858
2024
Q3
$1.78M Buy
62,435
+20,956
+51% +$618K ﹤0.01% 2787
2024
Q2
$1.1M Sell
41,479
-14,435
-26% -$411K ﹤0.01% 3140
2024
Q1
$1.81M Sell
55,914
-52
-0.1% -$1.9K ﹤0.01% 2711
2023
Q4
$2.36M Sell
55,966
-86,598
-61% -$3.19M ﹤0.01% 2538
2023
Q3
$5.47M Sell
142,564
-620,647
-81% -$14M 0.01% 1735
2023
Q2
$14.5M Buy
763,211
+318,758
+72% +$5.94M 0.02% 1078
2023
Q1
$6.89M Buy
444,453
+145,983
+49% +$2.53M 0.01% 1676
2022
Q4
$5.3M Buy
+298,470
New +$3.76M 0.01% 2042
2022
Q1
Sell
-20,371
Closed -$174K 5740
2021
Q4
$174K Buy
+20,371
New +$168K ﹤0.01% 4932
2021
Q2
Sell
-25,119
Closed -$403K 4888
2021
Q1
$403K Buy
+25,119
New +$662K ﹤0.01% 3599

Other funds holding IMVT